BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33749772)

  • 1. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
    Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population-based study.
    Väyrynen V; Wirta EV; Seppälä T; Sihvo E; Mecklin JP; Vasala K; Kellokumpu I
    BJS Open; 2020 Aug; 4(4):685-692. PubMed ID: 32543788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.
    Osterlund P; Salminen T; Soveri LM; Kallio R; Kellokumpu I; Lamminmäki A; Halonen P; Ristamäki R; Lantto E; Uutela A; Osterlund E; Ovissi A; Nordin A; Heervä E; Lehtomäki K; Räsänen J; Murashev M; Aroviita L; Jekunen A; Lindvall-Andersson R; Nyandoto P; Kononen J; Lepistö A; Poussa T; Muhonen T; Ålgars A; Isoniemi H;
    Lancet Reg Health Eur; 2021 Apr; 3():100049. PubMed ID: 34557799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative-intent treatment of recurrent colorectal liver metastases: A comparison between ablation and resection.
    Dupré A; Jones RP; Diaz-Nieto R; Fenwick SW; Poston GJ; Malik HZ
    Eur J Surg Oncol; 2017 Oct; 43(10):1901-1907. PubMed ID: 28888801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver resection surgery compared with thermal ablation in high surgical risk patients with colorectal liver metastases: the LAVA international RCT.
    Davidson B; Gurusamy K; Corrigan N; Croft J; Ruddock S; Pullan A; Brown J; Twiddy M; Birtwistle J; Morris S; Woodward N; Bandula S; Hochhauser D; Prasad R; Olde Damink S; Coolson M; Laarhoven KV; de Wilt JH
    Health Technol Assess; 2020 Apr; 24(21):1-38. PubMed ID: 32370822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma.
    Shah SA; Haddad R; Al-Sukhni W; Kim RD; Greig PD; Grant DR; Taylor BR; Langer B; Gallinger S; Wei AC
    J Am Coll Surg; 2006 Mar; 202(3):468-75. PubMed ID: 16500252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
    Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
    Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeat hepatic resection for colorectal liver metastases.
    Adair RA; Young AL; Cockbain AJ; Malde D; Prasad KR; Lodge JP; Toogood GJ
    Br J Surg; 2012 Sep; 99(9):1278-83. PubMed ID: 22864889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases.
    Andres A; Mentha G; Adam R; Gerstel E; Skipenko OG; Barroso E; Lopez-Ben S; Hubert C; Majno PE; Toso C
    Br J Surg; 2015 May; 102(6):691-9. PubMed ID: 25789941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Garlipp B; Gibbs P; Van Hazel GA; Jeyarajah R; Martin RCG; Bruns CJ; Lang H; Manas DM; Ettorre GM; Pardo F; Donckier V; Benckert C; van Gulik TM; Goéré D; Schoen M; Pratschke J; Bechstein WO; de la Cuesta AM; Adeyemi S; Ricke J; Seidensticker M
    Br J Surg; 2019 Dec; 106(13):1837-1846. PubMed ID: 31424576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases.
    Capussotti L; Muratore A; Mulas MM; Massucco P; Aglietta M
    Br J Surg; 2006 Aug; 93(8):1001-6. PubMed ID: 16739103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases.
    Elias D; Ouellet JF; Bellon N; Pignon JP; Pocard M; Lasser P
    Br J Surg; 2003 May; 90(5):567-74. PubMed ID: 12734864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes of liver metastasectomy in colorectal cancer cases: a single-center analysis in Turkey.
    Cokmert S; Ellidokuz H; Demir L; Fuzun M; Astarcioglu I; Aslan D; Yilmaz U; Oztop I
    Asian Pac J Cancer Prev; 2014; 15(13):5195-200. PubMed ID: 25040974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.
    Uutela A; Osterlund E; Halonen P; Kallio R; Ålgars A; Salminen T; Lamminmäki A; Soveri LM; Ristamäki R; Lehtomäki K; Stedt H; Heervä E; Muhonen T; Kononen J; Nordin A; Ovissi A; Kytölä S; Keinänen M; Sundström J; Nieminen L; Mäkinen MJ; Kuopio T; Ristimäki A; Isoniemi H; Osterlund P
    Br J Cancer; 2022 Sep; 127(4):686-694. PubMed ID: 35610367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?
    Bakalakos EA; Burak WE; Young DC; Martin EW
    Am J Surg; 1999 Jan; 177(1):2-6. PubMed ID: 10037299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases.
    Angelsen JH; Viste A; Løes IM; Eide GE; Hoem D; Sorbye H; Horn A
    World J Surg Oncol; 2015 Dec; 13():328. PubMed ID: 26631156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Bachet JB; Moreno-Lopez N; Vigano L; Marchese U; Gelli M; Raoux L; Truant S; Laurent C; Herrero A; Le Roy B; Deguelte Lardiere S; Passot G; Hautefeuille V; De La Fouchardiere C; Artru P; Ameto T; Mabrut JY; Schwarz L; Rousseau B; Lepère C; Coriat R; Brouquet A; Sa Cunha A; Benoist S
    Br J Surg; 2019 Aug; 106(9):1237-1247. PubMed ID: 31183866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases.
    Gonzalez M; Robert JH; Halkic N; Mentha G; Roth A; Perneger T; Ris HB; Gervaz P
    World J Surg; 2012 Feb; 36(2):386-91. PubMed ID: 22167262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resection of Concomitant Hepatic and Extrahepatic Metastases from Colorectal Cancer - A Worthwhile Operation?
    Diaconescu A; Alexandrescu S; Ionel Z; Zlate C; Grigorie R; Brasoveanu V; Hrehoret D; Ciurea S; Botea F; Tomescu D; Droc G; Croitoru A; Herlea V; Boros M; Grasu M; Dumitru R; Toma M; Ionescu M; Vasilescu C; Popescu I
    Chirurgia (Bucur); 2017; 112(6):673-682. PubMed ID: 29288609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant systemic chemotherapy after putative curative resection of colorectal liver and lung metastases.
    Brandi G; Derenzini E; Falcone A; Masi G; Loupakis F; Pietrabissa A; Pinna AD; Ercolani G; Pantaleo MA; Di Girolamo S; Grazi GL; de Rosa F; Biasco G
    Clin Colorectal Cancer; 2013 Sep; 12(3):188-94. PubMed ID: 23773458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.